- Wed 6/5; vol. 950K
Showing posts with label REPL. Show all posts
Showing posts with label REPL. Show all posts
Friday, June 7, 2024
Friday, July 20, 2018
Replimune (REPL) began trading on the Nasdaq on 20 July 2018
Replimune Group, Inc., a clinical-stage biotechnology company, focuses on the development of oncolytic immunotherapies to treat cancer.
Replimune priced 6.7 mln share IPO at $15.00, the midpoint of the expected $14.00-16.00 range.
Ppened for trading at $16
- Sector: Healthcare
- Industry: Biotechnology
- Full Time Employees: 52
- Founded in 2015
- Headquartered in Woburn, Massachusetts
- http://www.replimune.com
Replimune priced 6.7 mln share IPO at $15.00, the midpoint of the expected $14.00-16.00 range.
Ppened for trading at $16
Subscribe to:
Posts (Atom)